Bing Ren, Ph.D., associate professor of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine and head of the Laboratory of Gene Regulation at the Ludwig Institute for Cancer Research, was recently selected as one of four grant recipients in the National Institutes of Health (NIH) Roadmap’s Epigenomics Program, an initiative developed to study stable genetic modifications that affect and alter the behavior of genes across the human genome.